Mrkt BUZZ Immunovia: Eventful Q2 and rights issue to support PancreaSure launch
Carlsquare Equity Research has published a comment following the publication of the Q2 report for 2025.
Read the full comment here.
Carlsquare Equity Research has published a comment following the publication of the Q2 report for 2025.
Read the full comment here.